These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 35703314)

  • 1. Evaluation protocol for CRISPR/Cas9-mediated CD19 knockout GM24385 cells by flow cytometry and Sanger sequencing.
    Inwood SL; Tian L; Parratt K; Maragh S; Wang L
    Biotechniques; 2022 Jun; 72(6):279-286. PubMed ID: 35703314
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assaying Cell Cycle Progression via Flow Cytometry in CRISPR/Cas9-Treated Cells.
    Geisinger JM; Stearns T
    Methods Mol Biol; 2021; 2329():195-204. PubMed ID: 34085224
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Temperature effect on CRISPR-Cas9 mediated genome editing.
    Xiang G; Zhang X; An C; Cheng C; Wang H
    J Genet Genomics; 2017 Apr; 44(4):199-205. PubMed ID: 28412228
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A simple, quick, and efficient CRISPR/Cas9 genome editing method for human induced pluripotent stem cells.
    Geng BC; Choi KH; Wang SZ; Chen P; Pan XD; Dong NG; Ko JK; Zhu H
    Acta Pharmacol Sin; 2020 Nov; 41(11):1427-1432. PubMed ID: 32555510
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic Genome Editing and In Vivo Delivery.
    Ramirez-Phillips AC; Liu D
    AAPS J; 2021 Jun; 23(4):80. PubMed ID: 34080099
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ex Vivo Expansion and CRISPR-Cas9 Genome Editing of Primary Human Natural Killer Cells.
    Huang RS; Lai MC; Lin S
    Curr Protoc; 2021 Sep; 1(9):e246. PubMed ID: 34529358
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasmid-based CRISPR-Cas9 system efficacy for introducing targeted mutations in CD81 gene of MDA-MB-231 cell line.
    Arbabi Zaboli K; Rahimi H; Thekkiniath J; Taromchi AH; Kaboli S
    Folia Histochem Cytobiol; 2022; 60(1):13-23. PubMed ID: 35157300
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High efficient multisites genome editing in allotetraploid cotton (Gossypium hirsutum) using CRISPR/Cas9 system.
    Wang P; Zhang J; Sun L; Ma Y; Xu J; Liang S; Deng J; Tan J; Zhang Q; Tu L; Daniell H; Jin S; Zhang X
    Plant Biotechnol J; 2018 Jan; 16(1):137-150. PubMed ID: 28499063
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CRISPR/Cas9: an advanced tool for editing plant genomes.
    Samanta MK; Dey A; Gayen S
    Transgenic Res; 2016 Oct; 25(5):561-73. PubMed ID: 27012546
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Challenges of in vitro genome editing with CRISPR/Cas9 and possible solutions: A review.
    Ebrahimi V; Hashemi A
    Gene; 2020 Aug; 753():144813. PubMed ID: 32470504
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Profiling Genome-Wide Specificity of CRISPR-Cas9 Using Digenome-Seq.
    Kim D; Kim JS
    Methods Mol Biol; 2021; 2162():233-242. PubMed ID: 32926386
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Simple Protocol for Generating and Genotyping Genome-Edited Mice With CRISPR-Cas9 Reagents.
    Fernández A; Morín M; Muñoz-Santos D; Josa S; Montero A; Rubio-Fernández M; Cantero M; Fernández J; Del Hierro MJ; Castrillo M; Moreno-Pelayo MÁ; Montoliu L
    Curr Protoc Mouse Biol; 2020 Mar; 10(1):e69. PubMed ID: 32159922
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optical Control of a CRISPR/Cas9 System for Gene Editing by Using Photolabile crRNA.
    Zhang Y; Ling X; Su X; Zhang S; Wang J; Zhang P; Feng W; Zhu YY; Liu T; Tang X
    Angew Chem Int Ed Engl; 2020 Nov; 59(47):20895-20899. PubMed ID: 33448579
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genome Editing by CRISPR/Cas9 in Sorghum Through Biolistic Bombardment.
    Liu G; Li J; Godwin ID
    Methods Mol Biol; 2019; 1931():169-183. PubMed ID: 30652290
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CRISPR/Cas9-mediated genome editing in sea urchins.
    Lin CY; Oulhen N; Wessel G; Su YH
    Methods Cell Biol; 2019; 151():305-321. PubMed ID: 30948015
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Precise and efficient scarless genome editing in stem cells using CORRECT.
    Kwart D; Paquet D; Teo S; Tessier-Lavigne M
    Nat Protoc; 2017 Feb; 12(2):329-354. PubMed ID: 28102837
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Investigation of Genetic Dependencies Using CRISPR-Cas9-based Competition Assays.
    Deshpande A; Chen BR; Zhao L; Saddoris K; Kerr M; Zhu N; Mali P; Deshpande AJ
    J Vis Exp; 2019 Jan; (143):. PubMed ID: 30663717
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CRISPR/Cas9 System and its Research Progress in Gene Therapy.
    Liu W; Yang C; Liu Y; Jiang G
    Anticancer Agents Med Chem; 2019; 19(16):1912-1919. PubMed ID: 31633477
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Baculoviral delivery of CRISPR/Cas9 facilitates efficient genome editing in human cells.
    Hindriksen S; Bramer AJ; Truong MA; Vromans MJM; Post JB; Verlaan-Klink I; Snippert HJ; Lens SMA; Hadders MA
    PLoS One; 2017; 12(6):e0179514. PubMed ID: 28640891
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Flow cytometry-based quantification of genome editing efficiency in human cell lines using the L1CAM gene.
    Hasan MN; Hyodo T; Biswas M; Rahman ML; Mihara Y; Karnan S; Ota A; Tsuzuki S; Hosokawa Y; Konishi H
    PLoS One; 2023; 18(11):e0294146. PubMed ID: 37943774
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.